6 Einträge gefunden

1. HER2-targeted therapy influences CTC status in metastatic breast cancer

   1. Deutsch, Thomas M
   2. Riethdorf, Sabine
   3. Fremd, Carlo
   4. Feisst, Manuel
   5. Nees, Juliane
   6. Fischer, Chiara
   7. Hartkopf, Andreas D

   2020 - Forschungsinformationssystem des UKE
2. Plasma S100P level as a novel prognostic marker of metastatic breast cancer

   1. Peng, Cike
   2. Chen, Hongda
   3. Wallwiener, Markus
   4. Modugno, Caroline
   5. Cuk, Katarina
   6. Madhavan, Dharanija
   7. Trumpp, Andreas

   2016 - Forschungsinformationssystem des UKE
3. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis

   1. Madhavan, Dharanija
   2. Peng, Cike
   3. Wallwiener, Markus
   4. Zucknick, Manuela
   5. Nees, Juliane
   6. Schott, Sarah
   7. Rudolph, Anja

   2016 - Forschungsinformationssystem des UKE
4. The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

   1. Wallwiener, Markus
   2. Hartkopf, Andreas Daniel
   3. Riethdorf, Sabine
   4. Nees, Juliane
   5. Sprick, Martin Ronald
   6. Schönfisch, Birgitt
   7. Taran, Florin-Andrei

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
5. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

   1. Madhavan, Dharanija
   2. Wallwiener, Markus
   3. Bents, Karin
   4. Zucknick, Manuela
   5. Nees, Juliane
   6. Schott, Sarah
   7. Cuk, Katarina

   2014 - Forschungsinformationssystem des UKE
6. The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.

   1. Wallwiener, Markus
   2. Hartkopf, Andreas Daniel
   3. Baccelli, Irène
   4. Riethdorf, Sabine
   5. Schott, Sarah
   6. Pantel, Klaus
   7. Marmé, Frederik

   2013 - Forschungsinformationssystem des UKE